The specialty’s leading advocate, the Advocacy Council, is committed to bringing you news and insights on billing, coding and policy reform that directly affect your practice. Advocacy Insider, a recurring column in College Insider, keeps you in the loop.
Contact us at AdvocacyCouncil@acaai.org or 847-427-1200.
- Show all
- A/I Action
- Advocacy Alert
- Advocacy Resources
- AllergyWatch
- Annals
- Annual Meeting
- CA2PER Program
- Career Center
- College Advantage
- Committees
- Course
- COVID-19
- Disaster Resources
- Education
- Event
- Foundation
- From College Leadership
- Gold Headed Cane
- History
- House of Delegates
- Leadership
- Member benefit
- New Allergists
- News
- Opinion
- Pathways to Practice
- Patient Brochures
- Payer Education Campaign
- Practice Parameter
- Resources
- Senior Allergist Forum
- Survey
- Time For An Allergist
- Uncategorized
- Webinar
- Women in Allergy
Tezspire administration remains an in-office procedure
Medicare Administrative Contractors publicly announced removal of Tezspire from their Self-Administration Drug (SAD) exclusion lists.
Drug prices lowered for Medicare beneficiaries and ACA subsidies extended
After more than a year of trying to pass the Build Back Better Act, Congress passed a slimmer version, the Inflation Reduction Act.
Telehealth – Proposed bill extends coverage through the end of 2024
The COVID-19 Public Health Emergency could end before Congress determines how to permanently expand these coverage policies.
Billing – how do your claims compare to other allergists?
Only allergists with billing patterns significantly higher than either their peer group or national averages will receive a CBR.
Tezspire – advocacy thwarts move to SAD list
Due to the efforts of the Advocacy Council and other medical organizations, Tezspire administration remains in the physician office setting.
Telehealth and HIPAA Compliance
HHS recently issued guidance clarifying how providers may use remote communication technologies for audio-only telehealth services after the conclusion of the …
Peanut Allergy – we testify on behalf of our patients
This event was organized by the National Peanut Board.
2023 cuts in reimbursement – we advocate against them
These looming cuts are the result of several policies that have a combined effect of reducing Medicare payments by as much as 9%.
95004 – Medicare billing and coding guidance
Billing requirements may vary by payer, so allergists should consult with the payer to determine their billing and coding requirements.
Keeping up with compounding
At the FDA Annual Compounding Listening Session, a number of compounding topics were discussed, such as marketing of IV rehydration clinics.
